Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating

International Journal of Pharmaceutics

Volumn 474, Issue 1-2, 2014, Pages 95-102

  Mei, Ling ^a   Zhang, Qianyu ^a   Yang, Yuting ^a   He, Qin ^a   Gao, Huile ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Activatable cell penetrating peptide; Angiopep 2; Glioma; Systemic targeting delivery

Indexed keywords

ANGIOPEP 2; CELL PENETRATING PEPTIDE; GELATINASE A; LIGAND; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; NANOPARTICLE; UNCLASSIFIED DRUG; ANGIOPEP 2 CELL PENETRATING PEPTIDE NANOPARTICLE CONJUGATE; ANTIBODY; ANTINEOPLASTIC AGENT; ARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLARGININE; CD31 ANTIBODY; DRUG CARRIER; GLUTAMYLGLUTAMYLGLUTAMYLGLUTAMYLGLUTAMYLGLUTAMYLGLUTAMYLGLUTAMIC ACID; MACROGOL; POLYCAPROLACTONE; ANGIOPEP-2; PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOSOME; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; TUMOR VOLUME; ANIMAL MODEL; ANIMAL TISSUE; CONCENTRATION RESPONSE; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG UPTAKE; FLUORESCENCE ANALYSIS; GLIOMA CELL LINE; HUMAN; HUMAN CELL; INTERNALIZATION; TUMOR CELL; CHEMISTRY; GLIOMA; METABOLISM; PARTICLE SIZE; PATHOLOGY; SURFACE PROPERTY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS; GLIOMA; HUMANS; LIGANDS; NANOPARTICLES; PARTICLE SIZE; PEPTIDES; SURFACE PROPERTIES;

EID: 84906668506     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.08.020     Document Type: Article

References (41)

1. L. Alberici, L. Roth, K.N. Sugahara, L. Agemy, V.R. Kotamraju, T. Teesalu, C. Bordignon, C. Traversari, G.P. Rizzardi, and E. Ruoslahti De novo design of a tumor-penetrating peptide Cancer Res. 73 2013 804 812
2. Y.H. Bae, and K. Park Targeted drug delivery to tumors: myths, reality and possibility J. Control. Release 153 2011 198 205
3. ® - the first FDA-approved nano-drug: lessons learned J. Control. Release 160 2012 117 134
4. P. Debbage Targeted drugs and nanomedicine: present and future Curr. Pharm. Des. 15 2009 153 172
5. M. Demeule, J.C. Currie, Y. Bertrand, C. Che, T. Nguyen, A. Regina, R. Gabathuler, J.P. Castaigne, and R. Beliveau Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2 J. Neurochem. 106 2008 1534 1544
6. J. Fang, H. Nakamura, and H. Maeda The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Deliv. Rev. 63 2011 136 151
7. A.T. Florence Targeting nanoparticles: the constraints of physical laws and physical barriers J. Control. Release 164 2012 115 124
8. C. Foged, and H.M. Nielsen Cell-penetrating peptides for drug delivery across membrane barriers Exp. Opin. Drug Deliv. 5 2008 105 117 (Pubitemid 351234112)
9. P.A. Forsyth, H. Wong, T.D. Laing, N.B. Rewcastle, D.G. Morris, H. Muzik, K.J. Leco, R.N. Johnston, P.M. Brasher, G. Sutherland, and D.R. Edwards Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas Br. J. Cancer 79 1999 1828 1835 (Pubitemid 29132312)
10. H. Gao, S. Pan, Z. Yang, S. Cao, C. Chen, X. Jiang, S. Shen, Z. Pang, and Y. Hu A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein Biomaterials 32 2011 8669 8675
11. H. Gao, Z. Yang, S. Zhang, S. Cao, S. Shen, Z. Pang, and X. Jiang Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization Sci. Rep. 3 2013 2534
12. H. Gao, S. Cao, C. Chen, S. Cao, Z. Yang, Z. Pang, Z. Xi, S. Pan, Q. Zhang, and X. Jiang Incorporation of lapatinib into lipoprotein-like nanoparticles with enhanced water solubility and anti-tumor effect in breast cancer Nanomedicine (Lond.) 8 2013 1429 1442
13. W. Gao, B. Xiang, T.T. Meng, F. Liu, and X.R. Qi Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides Biomaterials 34 2013 4137 4149
14. H. Gao, S. Zhang, S. Cao, Z. Yang, Z. Pang, and X. Jiang Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery Mol. Pharm. 2014
15. H. Gao, Z. Yang, S. Zhang, Z. Pang, Q. Liu, and X. Jiang Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays Acta Biomater. 10 2014 858 867
16. H. Gao, Y. Xiong, S. Zhang, Z. Yang, S. Cao, and X. Jiang RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration Mol. Pharm. 11 2014 1042 1052
17. H. Gao, Z. Yang, S. Cao, Y. Xiong, S. Zhang, Z. Pang, and X. Jiang Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment Biomaterials 35 2014 2374 2382
18. S.K. Hobbs, W.L. Monsky, F. Yuan, W.G. Roberts, L. Griffith, V.P. Torchilin, and R.K. Jain Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc. Natl. Acad. Sci. U. S. A. 95 1998 4607 4612 (Pubitemid 28207960)
19. S. Ito, S. Ohtsuki, and T. Terasaki Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier Neurosci. Res. 56 2006 246 252 (Pubitemid 44572534)
20. T. Jiang, E.S. Olson, Q.T. Nguyen, M. Roy, P.A. Jennings, and R.Y. Tsien Tumor imaging by means of proteolytic activation of cell-penetrating peptides Proc. Natl. Acad. Sci. U. S. A. 101 2004 17867 17872 (Pubitemid 40051978)
21. E. Kluza, I. Jacobs, S.J. Hectors, K.H. Mayo, A.W. Griffioen, G.J. Strijkers, and K. Nicolay Dual-targeting of alphavbeta3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo J. Control. Release 158 2012 207 214
22. E. Kondo, K. Saito, Y. Tashiro, K. Kamide, S. Uno, T. Furuya, M. Mashita, K. Nakajima, T. Tsumuraya, N. Kobayashi, M. Nishibori, M. Tanimoto, and M. Matsushita Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems Nat. Commun. 3 2012 951
23. R. Kuai, W. Yuan, W. Li, Y. Qin, J. Tang, M. Yuan, L. Fu, R. Ran, Z. Zhang, and Q. He Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration Mol. Pharm. 8 2011 2151 2161
24. T. Lammers, F. Kiessling, W.E. Hennink, and G. Storm Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J. Control. Release 161 2012 175 187
25. Y. Liu, M. Ji, M.K. Wong, K.I. Joo, and P. Wang Enhanced therapeutic efficacy of iRGD-conjugated crosslinked multilayer liposomes for drug delivery Biomed. Res. Int. 2013 2013 1 11
26. Y. Liu, Y.J. Kim, M. Ji, J. Fang, N. Siriwon, L.I. Zhang, and P. Wang Enhancing gene delivery of adeno-associated viruses by cell-permeable peptides Mol. Ther. Methods Clin. Dev. 1 2014 12
27. Y. Liu, R. Ran, J. Chen, Q. Kuang, J. Tang, L. Mei, Q. Zhang, H. Gao, Z. Zhang, and Q. He Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting Biomaterials 35 2014 4835 4847
28. W. Lu, Y. Zhang, Y.Z. Tan, K.L. Hu, X.G. Jiang, and S.K. Fu Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery J. Control. Release 107 2005 428 448 (Pubitemid 41393353)
29. W. Lu, Q. Sun, J. Wan, Z. She, and X.G. Jiang Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration Cancer Res. 66 2006 11878 11887 (Pubitemid 46094200)
30. M. Mahmoudi, K. Azadmanesh, M.A. Shokrgozar, W.S. Journeay, and S. Laurent Effect of nanoparticles on the cell life cycle Chem. Rev. 111 2011 3407 3432
31. L. Maletinska, E.A. Blakely, K.A. Bjornstad, D.F. Deen, L.J. Knoff, and T.M. Forte Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein Cancer Res. 60 2000 2300 2303 (Pubitemid 30225197)
32. F. Marcucci, and F. Lefoulon Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress Drug Discov. Today 9 2004 219 228 (Pubitemid 38230021)
33. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392 (Pubitemid 17221789)
34. E.S. Olson, T. Jiang, T.A. Aguilera, Q.T. Nguyen, L.G. Ellies, M. Scadeng, and R.Y. Tsien Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases Proc. Natl. Acad. Sci. U. S. A. 107 2010 4311 4316
35. Z. Pang, W. Lu, H. Gao, K. Hu, J. Chen, C. Zhang, X. Gao, X. Jiang, and C. Zhu Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26 J. Control. Release 128 2008 120 127
36. Y. Qin, H. Chen, W. Yuan, R. Kuai, Q. Zhang, F. Xie, L. Zhang, Z. Zhang, J. Liu, and Q. He Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery Int. J. Pharm. 419 2011 85 95
37. N. Svensen, J.G. Walton, and M. Bradley Peptides for cell-selective drug delivery Trends Pharmacol. Sci. 33 2012 186 192
38. J. Tang, L. Zhang, Y. Liu, Q. Zhang, Y. Qin, Y. Yin, W. Yuan, Y. Yang, Y. Xie, Z. Zhang, and Q. He Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT Int. J. Pharm. 454 2013 31 40
39. H. Xin, X. Jiang, J. Gu, X. Sha, L. Chen, K. Law, Y. Chen, X. Wang, Y. Jiang, and X. Fang Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon- caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma Biomaterials 32 2011 4293 4305
40. H. Yan, L. Wang, J. Wang, X. Weng, H. Lei, X. Wang, L. Jiang, J. Zhu, W. Lu, X. Wei, and C. Li Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier ACS Nano 6 2012 410 420
41. R. van der Meel, L.J. Vehmeijer, R.J. Kok, G. Storm, and E.V. van Gaal Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status Adv. Drug Deliv. Rev. 65 2013 1284 1298